Abivax (ABVX) Free Cash Flow (2024 - 2026)
Abivax (ABVX) recorded quarterly Free Cash Flow of $63220.3 in Q1 2026, up 100.23% quarter-over-quarter from -$27.2 million in Q4 2025, and up 100.18% on a YoY basis from $31581.6 in Q1 2025.
Abivax (ABVX) Free Cash Flow (2024 - 2026) Analysis & Trends
Abivax's Free Cash Flow history runs 3 years deep, the most recent figure standing at $63220.3 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 100.18% year-over-year to $63220.3; the TTM figure through Mar 2026 stood at -$148.2 million (up 9.97% YoY), while the FY2025 annual figure was -$187.7 million, down 13.51% from the prior year.
- Free Cash Flow was $63220.3 for Q1 2026 at Abivax, up from -$27.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $63220.3 in Q1 2026 to a low of -$83.3 million in Q3 2025.
- Historically, Free Cash Flow has averaged -$39.0 million across 3 years, with a median of -$37.7 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow sank 116.38% in 2025, then jumped 100.18% in 2026.
- A 3-year view of Free Cash Flow shows it stood at -$37.1 million in 2024, then rose by 26.62% to -$27.2 million in 2025, then soared by 100.23% to $63220.3 in 2026.
- The last three Free Cash Flow figures came in at $63220.3 (Q1 2026), -$27.2 million (Q4 2025), and -$83.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 63,220.27 |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 848.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,220.27 |
| Mar 31, 2026 | 63,220.27 |
| Dec 31, 2025 | -27.23 Mn |
| Dec 31, 2025 | -27.23 Mn |
| Sep 30, 2025 | -83.34 Mn |
| Sep 30, 2025 | -83.34 Mn |
| Jun 30, 2025 | -37.72 Mn |
| Jun 30, 2025 | -37.72 Mn |
| Mar 31, 2025 | -34.96 Mn |
| Mar 31, 2025 | -34.96 Mn |
| Dec 31, 2024 | -37.11 Mn |
| Dec 31, 2024 | -37.11 Mn |
| Sep 30, 2024 | -38.52 Mn |
| Sep 30, 2024 | -38.52 Mn |
| Jun 30, 2024 | -54.06 Mn |
| Jun 30, 2024 | -54.06 Mn |
| Mar 31, 2024 | -37.74 Mn |
| Mar 31, 2024 | -37.74 Mn |